US prescriptions for Novo Nordisk's (NOVOB DC) Wegovy pill were 26,109 for week ended Jan 23, IQVIA data shows
The increase in prescriptions for Novo Nordisk's Wegovy pill suggests positive momentum for the company, likely reflecting strong demand for obesity treatments.
CHMP adopts positive opinion for the marketing authorization of Bayer's (BAYN GY) Finerenone for patients with heart failure with left ventricular ejection fraction ≥40%
Top Iranian security official says Iran to list armed forces of EU countries that blacklisted revolutionary guards as 'Terrorist'
US prescriptions for Novo Nordisk's (NOVOB DC) Wegovy pill were 26,109 for week ended Jan 23, IQVIA data shows
Iranian Foreign Minister regarding US threats, says outcome of negotiations cannot be dictated before the talks and nuclear programme will not be part of talks; will not negotiate its defence capabilities
Russian foreign ministry says Russia will use all the available means to defend vessels under Russian flags in case their rights are violated
Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.
This uptick may impact revenue forecasts and could lead to favorable analyst upgrades, indicating that the market sentiment around NOVOB.DC could shift more positively if this trend persists, particularly within the health and pharmaceuticals sector.
Related headlines
- Novo Nordisk (NOVOB DC) announced first results from the STEP Young phase 3 trial; The trial met its primary endpoint, demonstrating superior body mass index reduction at week 682 days ago
- Crystler (STLAM IM/STLAP FP) files to recall over 200k US vehicles18 hours ago
- European Movers: Airbus (AIR FP) -1.3%, LVMH (MC FP) -1.3%, Orsted (ORSTED DC) -1.6%, Inditex (ITX SM) -3%, Burberry (BRBY LN) -3%18 hours ago
- Additional European Equity News - 9th September 202619 hours ago
- European Equity pre-Market Summary - 9th September 2026: European bourses are indicative of a slightly softer open; Inditex reports poor results19 hours ago
- Newsquawk Daily European Equity Opening News - 9th September 202620 hours ago
- European Movers: Airbus (AIR FP) -0.7%, Schneider Electric (SU FP) -0.9%, Société Générale (GLE FP) -1.6%, Infineon (IFX GY) -1.9%, Novartis (NOVN SW) -9%, 1 day ago
- Additional European Equity News - 8th September 20261 day ago
- European Equity pre-Market Summary - 8th September 2026: Novartis does not meet Phase 3 primary endpoint; European equity futures indicative of a slightly lower open, as energy picks up1 day ago
- Newsquawk Daily European Equity Opening News - 8th September 20261 day ago
- Fiat Chrysler, now part of Stellantis (STLA IM/STLA FP), will stand trial before the Paris Criminal Court for aggravated fraud in connection with the vast "Dieselgate" scandal, AFP reports, citing a source2 days ago
- Deutsche Telekom (DTE GY), Orange (ORA FP), Vodafone (VOD LN), Telefonica in venture talks (TEF SM); in talks for satellite-to-mobile venture2 days ago
- European Movers: Ferrexpo (FXPO LN) +10%, STMicroelectronics (STMPA FP) +2.0%, ASML (ASML NA) +1.6%, E.ON (EOAN GY) +1.0%, EssilorLuxottica (EL FP) -1.2%2 days ago
- European Equity pre-Market Summary - 7th September 2026: European bourses look set for a muted open, with volumes light as the US takes a holiday2 days ago
- Additional European Equity News - 7th September 20262 days ago
- Newsquawk Daily European Equity Opening News - 7th September 20262 days ago
- Portuguese Government says Air France-KLM (AF FP) and Lufthansa (LHA GY) have been asked to submit improved offers for a minority stake in TAP5 days ago
- EQT (EQT SS) has reached an agreement worth USD 2bln for the acquisition of insurance broker McGill, FT reports citing sources5 days ago
- Wacker Chemie (WCH GY) is reportedly considering closing its US plant after US President Trump's trade policy has driven customers away, according to sources5 days ago
- Chrysler (STLAM IM/STLAP FP) is recalling some 240k vehicles, NHTSA reports 5 days ago
The whole workspace, free to try.
Try it free